Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Accenture
Chubb
Johnson and Johnson
Federal Trade Commission
US Army
Chinese Patent Office
Teva
Medtronic
Novartis

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203495

« Back to Dashboard
NDA 203495 describes LOMAIRA, which is a drug marketed by Avanthi Inc and is included in one NDA. It is available from one supplier. Additional details are available on the LOMAIRA profile page.

The generic ingredient in LOMAIRA is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.

Summary for NDA: 203495

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 203495

Suppliers and Packaging for NDA: 203495

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LOMAIRA
phentermine hydrochloride
TABLET;ORAL 203495 ANDA KVK-TECH, INC. 10702-001 10702-001-03 30 TABLET in 1 BOTTLE (10702-001-03)
LOMAIRA
phentermine hydrochloride
TABLET;ORAL 203495 ANDA KVK-TECH, INC. 10702-001 10702-001-06 60 TABLET in 1 BOTTLE (10702-001-06)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength8MG
Approval Date:Sep 12, 2016TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Moodys
Fuji
Mallinckrodt
Healthtrust
Novartis
Express Scripts
Johnson and Johnson
Deloitte
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot